Shabnam Shalapour

机构：The University of Texas MD Anderson Cancer Center · ORCID：0000-0002-4743-3706

发表论文 93 篇 · 总被引 10002 次 · h-index 35

代表论文

• Type I conventional dendritic cells facilitate immunotherapy in pancreatic cancer (2024 · Science · 被引 60)
• IL-22 resolves MASLD via enterocyte STAT3 restoration of diet-perturbed intestinal homeostasis (2024 · Cell Metabolism · 被引 53)
• Angiotensin II receptor inhibition ameliorates liver fibrosis and enhances hepatocellular carcinoma infiltration by effector T cells (2023 · Proceedings of the National Academy of Sciences · 被引 51)
• Development of an engineered extracellular vesicles-based vaccine platform for combined delivery of mRNA and protein to induce functional immunity (2024 · Journal of Controlled Release · 被引 30)
• IRF1 regulates self-renewal and stress responsiveness to support hematopoietic stem cell maintenance (2023 · Science Advances · 被引 29)
• Distinct small molecule inhibitors of Kras specifically prime CTLA4 blockade therapy to transcriptionally reprogram Tregs and overcome resistance to suppress pancreas cancer (2025 · bioRxiv (Cold Spring Harbor Laboratory) · 被引 6)